Venmax Drugs & Pharmaceuticals Ltd vs ZYDUS LIFESCIENCES LTD

A side-by-side comparison of Venmax Drugs & Pharmaceuticals Ltd (VENMAX) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ZYDUS LIFESCIENCES LTD leads VENMAX vs ZYDUSLIFE on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability04
  • Growth01
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

ZYDUSLIFE takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

83.40
P/E ratio
22.36
1.10
P/B ratio
4.09
0.00%
Dividend yield
0.08%
₹0.17
EPS
₹50.09

Profitability

ZYDUSLIFE takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

2.70%
Return on equity
21.20%
5.29%
Return on capital
21.00%
-114.81%
EBITDA margin
31.00%
-1.23%
Net margin
18.87%

Growth

ZYDUSLIFE takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y) even
16.35%
2.82%
Profit CAGR (3Y)
34.80%

Size & financial health

ZYDUSLIFE takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹12 Cr
Market cap
₹1.13L Cr
₹1 Cr
Revenue
₹27,148 Cr
₹-0 Cr
Net profit
₹5,124 Cr
0.02
Debt / equity
0.31
Venmax Drugs & Pharmaceuticals Ltd
  • + ["Company is almost debt free.", "Debtor days have improved from 247 to 65.1 days."]
  • ["Promoter holding has decreased over last quarter: -3.34%", "Promoter holding is low: 10.5%"]
ZYDUS LIFESCIENCES LTD
  • + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
Venmax Drugs & Pharmaceuticals Ltd full analysis ZYDUS LIFESCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.